1. Home
  2. MCB vs GOSS Comparison

MCB vs GOSS Comparison

Compare MCB & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCB
  • GOSS
  • Stock Information
  • Founded
  • MCB 1999
  • GOSS 2015
  • Country
  • MCB United States
  • GOSS United States
  • Employees
  • MCB N/A
  • GOSS N/A
  • Industry
  • MCB Major Banks
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCB Finance
  • GOSS Health Care
  • Exchange
  • MCB Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • MCB 694.8M
  • GOSS 586.6M
  • IPO Year
  • MCB 2017
  • GOSS 2019
  • Fundamental
  • Price
  • MCB $79.26
  • GOSS $2.94
  • Analyst Decision
  • MCB Buy
  • GOSS Strong Buy
  • Analyst Count
  • MCB 2
  • GOSS 4
  • Target Price
  • MCB $84.50
  • GOSS $8.50
  • AVG Volume (30 Days)
  • MCB 55.4K
  • GOSS 3.3M
  • Earning Date
  • MCB 10-16-2025
  • GOSS 11-06-2025
  • Dividend Yield
  • MCB 0.76%
  • GOSS N/A
  • EPS Growth
  • MCB N/A
  • GOSS N/A
  • EPS
  • MCB 6.17
  • GOSS N/A
  • Revenue
  • MCB $274,307,000.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • MCB $13.56
  • GOSS N/A
  • Revenue Next Year
  • MCB $11.39
  • GOSS $30.65
  • P/E Ratio
  • MCB $12.89
  • GOSS N/A
  • Revenue Growth
  • MCB 10.33
  • GOSS N/A
  • 52 Week Low
  • MCB $47.08
  • GOSS $0.66
  • 52 Week High
  • MCB $81.33
  • GOSS $2.98
  • Technical
  • Relative Strength Index (RSI)
  • MCB 66.06
  • GOSS 76.74
  • Support Level
  • MCB $77.38
  • GOSS $2.41
  • Resistance Level
  • MCB $80.46
  • GOSS $2.71
  • Average True Range (ATR)
  • MCB 1.75
  • GOSS 0.19
  • MACD
  • MCB 0.39
  • GOSS 0.04
  • Stochastic Oscillator
  • MCB 77.91
  • GOSS 96.37

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: